Cargando…
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19
BACKGROUND: The clinical management of coronavirus disease 2019 (COVID-19) is dependent on understanding the underlying factors that contribute to the disease severity. In the absence of effective antiviral therapies, other host immunomodulatory therapies such as targeting inflammatory response are...
Autores principales: | Chang, De, Zhao, Peng, Zhang, Dawei, Dong, Jing-Hui, Xu, Zhe, Yang, Guang, Li, Bo-Yu, Liu, Hong-Xia, Li, Bo-An, Qin, Cheng-Feng, Peng, Xiao-Hua, Wang, Fu-Sheng, Xie, Li-Xin, Chen, Zhu, Dela Cruz, Charles S., Sharma, Lokesh, Qin, En-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305869/ https://www.ncbi.nlm.nih.gov/pubmed/32574840 http://dx.doi.org/10.1016/j.jaip.2020.06.015 |
Ejemplares similares
-
Host tolerance contributes to persistent viral shedding in COVID-19
por: Chang, De, et al.
Publicado: (2020) -
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
por: Chang, De, et al.
Publicado: (2020) -
Teaching an Old Intensivist Neutrophil Tricks: Using Alveolar Neutrophilia to Diagnose Ventilator-associated Pneumonia
por: Gautam, Samir, et al.
Publicado: (2019) -
Does inflammation help during COVID-19?
por: Sharma, Lokesh, et al.
Publicado: (2020) -
Chitotriosidase: a marker and modulator of lung disease
por: Chang, De, et al.
Publicado: (2020)